Purpose To determine inter-rater reliability of sarcoidosisrelated computed tomography (CT) findings that can be used for scoring of thoracic sarcoidosis. Materials and methods CT images of 51 patients with sarcoidosis were scored by five chest radiologists for various abnormal CT findings (22 in total) encountered in thoracic sarcoidosis. Using intra-class correlation coefficient (ICC) analysis, inter-rater reliability was analysed and reported according to the Guidelines for Reporting Reliability and Agreement Studies (GRRAS) criteria. A pre-specified sub-analysis was performed to investigate the effect of training. Scoring was trained in a distinct set of 15 scans in which all abnormal CT findings were represented. Results Median age of the 51 patients (36 men, 70 %) was 43 years (range 26 -64 years). All radiographic stages were present in this group. ICC ranged from 0.91 for honeycombing to 0.11 for nodular margin (sharp versus illdefined). The ICC was above 0.60 in 13 of the 22 abnormal findings. Sub-analysis for the best-trained observers demonstrated an ICC improvement for all abnormal findings and values above 0.60 for 16 of the 22 abnormalities. Conclusions In our cohort, reliability between raters was acceptable for 16 thoracic sarcoidosis-related abnormal CT findings.
Introduction
Thin-section computed tomography (CT) of the chest is increasingly used in the diagnosis of sarcoidosis. A multitude of abnormalities can be detected [1] [2] [3] [4] , but little is known about inter-rater agreement. There appears to be good reported agreement between raters in scoring a limited number of abnormal CT findings in sarcoidosis with kappa values ranging from 0.81 to 0.89. These results are based on studies focussing on correlations between abnormal CT findings and pulmonary function impairment; however, the number of raters as well as the number of abnormal CT findings studied has been limited [5] [6] [7] [8] [9] .
Little is known about prognostic and clinical implications of abnormal CT findings in sarcoidosis. The best evidence available comes from studies investigating changes in disease extent or abnormal CT findings in serial imaging [10] [11] [12] [13] [14] . In order to investigate the potential role of CT in clinical decision-making in sarcoidosis, the inter-rater agreement of CT scoring has to be determined, as reasonable agreement is a first requisite for clinical usefulness. It is also essential for applicability of study results in other centres and thus enables comparisons of clinical outcomes between sarcoidosis centres.
The aim of our study was to measure the inter-rater reliability of a large number of thoracic sarcoidosis-related abnormal CT findings. With these results, we will have a firm basis for future investigations.
Methods

Patient cohort
Our local medical ethical committee approved this retrospective study.
A random sample of 51 patients was drawn from a cohort of Dutch sarcoidosis patients from a single sarcoidosis referral centre in the Netherlands. All patients had available CT images in the Picture Archiving and Communication System (PACS). The cohort consisted of a mix of all radiographic stages [15] (including stage IV with fibrotic end-stage disease). All patients were diagnosed with sarcoidosis based on histology or met the criteria of the World Association of Sarcoidosis and Other Granulomatous disorders (WASOG). This entails appropriate clinical presentation, granulomas identified in one or more organs, multiple organ involvement, and no other cause for granulomatous reaction [16] .
Thin section CT acquisition protocol
All examinations were performed on a 16-detector-row computed tomography (CT) system (Brilliance-16; Philips, Cleveland, OH, USA). Inspiratory scans were volumetric acquisitions with a slice thickness 1.0, collimation 16×0.75 (120 kVp, 130 mA.s, 512 FOV) and reconstructed with a high spatial frequency algorithm. Expiration scans were static, post-expiratory acquisitions at three predefined levels (aortic arch, carina, and lung bases) at 2-cm intervals. In some patients, expiration scans were low-dose volumetric acquisitions. Imaging direction was from the apices to the diaphragm. All patients had an expiration scan. Of these, six were of insufficient quality to assess air trapping (12 %).
Abnormal CT findings
When deciding which abnormalities to score, it was considered important to a) prevent selection bias and b) form a wide basis on which future investigations could be conducted. Therefore, all possible sarcoidosis related abnormal CT findings previously described in interstitial lung and airway disease defined by the Fleischner Society glossary [17] were included. Also, more sarcoidosis-specific abnormalities like the galaxy and cluster sign were included. The result of this approach was a list of 22 items that had to be scored in each CT (Table 1) . The abnormalities were scored per lobe in a semi-quantitative way when they involved parenchymal disease, or listed as present/absent in the case of airway and pleural disease. The lingula was regarded as a separate lobe. Quantification of parenchymal disease was grouped into five categories: 0, absent; 1, 1 -25 %; 2, 26 -50 %; 3, 51 -75 %; Table 1 
Nodules
Nodules are rounded opacities up to 3 cm in diameter and were classified on their peribronchovascular, parenchymal, or subpleural location. The frequently encountered thickening of the bronchovascular interstitium was scored as peribronchovascular nodules, although in some cases there will also be some fibrosis involved. Parenchymal nodules are nodules that are neither peribronchovascular nor subpleural in location. In addition, the aspect of the nodules was characterized as coalescent or as having a sharp or illdefined margin. Ground glass caused by diffuse micronodules (granular groundglass) was scored both as parenchymal nodules and as groundglass (Fig. 1) . Furthermore, the galaxy and cluster sign were assessed and scored as nodules. Because these classical items represent patterns of, respectively, confluent and clustered nodular disease they were captured under the confluent and parenchymal nodular items.
Consolidations
Consolidations are areas with increased opacity and obscuration of underlying structures. They were classified as central and peripheral regarding one-third of the cross-sectional distance from the hilum to the peripheral pleural surface as the central zone. Round opacities lager than 3 cm with or without air bronchogram were scored as consolidations and not as masses (Fig. 2) . In the literature, fibrotic masses are also regarded as important features for pulmonary sarcoidosis. We captured these under central or peripheral consolidations.
Bronchial abnormalities
Bronchial abnormalities were classified as bronchiectasis and bronchial deformation. Bronchiectasis was scored when the findings were compliant with the Fleischner definition. Bronchial deformation is not defined by the Fleischner glossary, but is considered an important item in thoracic sarcoidosis. It was scored when bronchi or bronchioles were deformed with or without the presence of bronchial dilatation. Although angulated or crossing bronchi are typical features of deformation in the presence of fibrosis, deformation could also be scored if the bronchial lumen was narrowed as a result of external compression for instance due to enlarged lymph nodes (Fig. 3 ).
Pleural abnormalities
Pleural thickening had to be differentiated from pseudoplaques. Pseudoplaques are coalescent small nodules in contact with the visceral pleura. In this study these plaques were scored as subpleural nodules (Fig. 4 ).
Septal lines
Septal lines were scored if there was thickening of the interlobular septa. The thickening could be smooth as well as irregular. Lines not related to the interlobular septa were not scored ( Fig. 5 ).
Air trapping
In order to determine the presence of air trapping, expiration scans were used. If these were not available or inadequate according to the observers' discretion, not available (NA) was scored. The presence of air trapping was based on visual assessment; no measurements were performed. Air trapping was considered present when lung parenchyma failed to increase in attenuation and failed to decrease in volume.
Lymph node measurements
The largest lymph node was measured at three levels: mediastinal, right, and left hilar. Although no evidence exists, 10 mm short axis for mediastinal and 5 mm short axis for hilar lymph nodes was considered enlarged.
Training and thin-section CT scoring
In this study there were five raters. Raters 1 and 2 had several meetings discussing the qualitative and semi-quantitative way of scoring. Fifty unrelated CTs from sarcoidosis patients were used during these discussion and training sessions, and as a result, raters 1 and 2 received the most training. From this set of 50 CT scans, 15 were selected by raters 1 and 2 to serve as training scans. This selection was performed in such a way that all possible abnormal CT findings encountered and described in sarcoidosis were present. Rater 3 received a training session according to the continuous learning method in which all scans of the test cohort were scored by rater 3 observed and corrected by rater 1 [18] . Raters 4 and 5 only received a brief instruction on how to score explaining the qualitative and semi-quantitative approach. After scoring, ambiguities within the test cohort were discussed. The effect of training on the agreement of scoring was not assessed; there were no pre-and post-training scoring sessions. In the actual scoring process all 51 scans were independently scored by the five observers who were employed at two different institutions. Four observers were working at a sarcoidosis referral centre and the fifth observer at a tertiary care centre involved in lung transplantation. Observers 1 and 2 (DH and PJ) are chest radiologists involved in the design of the study. Observer 3 (MS) is a chest radiology clinical fellow, and observers 4 and 5 (HE and JH) are experienced (>10 years) chest radiologists not involved in designing the study protocol. All raters were aware of the fact that the scans concerned patients diagnosed with sarcoidosis. 
Statistical analysis
In compliance with the Guidelines for Reporting Reliability and Agreement Studies (GRRAS) criteria, variability of scoring sarcoidosis related abnormal CT findings was analysed by determining the inter-rater agreement [19] . As the spatial distribution of the abnormal CT findings over the lung was not the subject of investigation, the sum of the scores per lobe was used to create a continuous data set. This made analysis with an intra-class correlation coefficient (ICC) based on an analysis of variance (ANOVA) model possible. In addition, the twoway mixed approach was chosen; the scoring raters form a random sample from all possible raters so that the results apply to a general population of chest radiologists. This analysis was performed for all raters and also in a sub-analysis leaving out the two raters who only recieved a short intruction on how to score. A generally accepted scale considers an ICC value of <0.40 as poor reproducibility; ICC values in the range 0.40 to 0.75 indicate fair to good reproducibility, and an ICC value of greater than 0.75 shows excellent reproducibility [20] . For clinical use, an ICC value of at least 0.60 is recommended [21] . Data were analyzed with SPSS 22.
Results
Patient demographics and prevalence of CT findings
Patient demographics are presented in Table 2 . Median age of the 51 patients (36 men, 70 %) was 43 years (range 26 -64 years). All radiographic stages were present. Stage 2 was most frequently encountered followed by stage 3 (37 and 27 %, respectively). In Table 3 the prevalence of the scored items of observer 1 (DH) is shown. The most common abnormalities scored in this cohort are subpleural, peribronchovascular, and parenchymal nodules (86, 80, and 76 %, respectively), followed by architectural distortion and bronchial deformation (69 and 67 %, respectively). Lymphadenopathy was also frequently encountered with mediastinal, right hilar, and left hilar location in, respectively, 92, 76, and 73 % of the cases.
Inter-rater reliability
ICCs of all scored abnormal CT findings are presented in Table 4 . ICCs varied substantially between abnormal CT findings ranging from 0.804 for honeycombing to 0.112 for 
Discussion
In this study, we investigated the reliability of scoring chest CT findings in patients with thoracic sarcoidosis. The results show that although there is a considerable variation in ICCs between the various CT findings, scoring of most of these abnormalities is possible with good inter-rater reliability. Most items of the scoring system can therefore be used in diagnostic, prognostic and outcome studies in sarcoidosis. Current CT scoring systems are coarse and, in our opinion, do not use all available data from CT analysis. In this study it was our aim to develop a reproducible unbiased scoring system. It is important to stress that the aim of this study was not to correlate the scoring of CT findings with physiological parameters or outcome measures. It is possible that some of the CT items scored do not have a clinical significance or, in contrast, are clinically important, but lack a good agreement. At a later stage we will address this by correlating CT items with physiological parameters and other outcome measures. This way we hope to answer relevant clinical questions including comparing the prognostic value of HRCT versus PET/CT. The scoring method described in this manuscript is time consuming (10 -20 min per scan) and thus is not clinically applicable, but it does provide valuable data on unbiased scoring of all abnormal CT findings encountered in pulmonary sarcoidosis. We believe this article shows promising results enabling further investigations towards a clinically applicable scoring system.
To our knowledge, this is the first study focussing on the scoring reliability of all possible CT findings in patients with proven sarcoidosis. Because we were interested in whether any chest radiologist could score these abnormalities, we used five raters with different levels of training and experience in the field of chest radiology, an approach that has not been taken before. The strength of this study is that it primarily focussed on reliability and was conducted and presented according to the GRRAS guidelines [19] . This enables a straightforward interpretation and comparison with other reliability studies. Furthermore, all CT findings were defined according to generally accepted criteria [17] and we aimed to score morphology without interpretation. We accepted the fact that different pathological processes could be represented by the same abnormal CT finding. For instance, hilar radiating masses, although appearing to be fibrotic, often consist of fibrosis as well as active inflammation. Whether or not masses are fibrotic cannot always be differentiated on HRCT. Only serial imaging or PET/CT can demonstrate if they are fibrotic or also represent active inflammatory disease [22] . These hilar masses were regarded as consolidations and scored as being central or peripheral in location. The same applies for bronchial deformation. We accepted the fact that bronchial deformation in our scoring system can represent fibrosis, but also external compression by enlarged lymph nodes. In line with this, we also decided not to include descriptive items like the galaxy and cluster sign in our scoring system. Although these signs are considered to be virtually pathognomic and thus helpful in diagnosis sarcoidosis they can also be encountered in other diseases and are in fact interpretations of nodular disease and captured by the items confluent and parenchymal nodules [23] . We believe that for a scoring system to be successful and eventually clinically applicable, abnormalities need to be well-described, leaving little room for interpretation. For the above-mentioned reasons, we decided not to use existing semi-quantative scales used for HRCT assessment because these are biased by using a selection of CT items or focus on the disease outcome [6, 7, 24] . Because of the superiority of HRCT over chest radiography in detecting lymphadenopathy and parenchymal abnormalities, we also did not use existing chest radiography systems.
CT scoring systems
Although scoring methods are different there are a few studies describing the scoring of CT findings to compare our results with [5] [6] [7] [8] [9] 14] . In 2003, Drent et al described inter-rater agreement using the scoring system proposed by Oberstein [6, 25] . In this study, agreement was investigated between two observers for bronchovascular bundle thickening or irregularity (BVB), intra-parenchymal nodules (ND) and consolidations including groundglass opacification (PC), septal and non septal lines (LS), pleural thickening (PL), and lymphnode enlargement defined as having a short axis diameter of 1 cm or more (LN). ICCs in this study, which included 80 patients with proven sarcoidosis, ranged from 0.36 for LN and BVB to 0.43, 0.57, 0.62, and 0.78 for PL, LS, PC, and ND, respectively. Earlier, Abehsera et al investigated CT patterns of fibrosis in 80 patients with fibrotic pulmonary sarcoidosis [7] . They identified a bronchial distortion pattern including bronchial deformation and traction bronchiectasis with or without surrounding masses; a honeycombing pattern and a linear pattern including hilar peripheral lines, distorted septal reticulation and translobular lines. Agreement between two observers scoring these patterns was good with a kappa of 0.87 for recognizing the main CT pattern. However, no subanalysis was performed for the separate CT findings that defined the main patterns. In our study, four fibrosis-related abnormalities were scored: honeycombing, architectural distortion, bronchial deformation, and bronchiectasis. The ICCs of the latter two were lower compared to Abehsera. A possible explanation could be that it is difficult to distinguish bronchial deformation from bronchiectasis when they are located centrally with a surrounding mass (a common finding in pulmonary sarcoidosis). Abehsera et al. addressed this by defining both bronchiectasis and bronchial deformation as bronchial distortion. When we used that approach too, the ICC for bronchial distortion improved to 0.64. The question remains whether these abnormalities should be combined or scored separately. Although the combination yields a higher reliability, important information could be lost because deformation can be due to compression by lymph nodes and does not necessarily indicate fibrosis, while bronchiectasis usually does.
Chest radiographic scoring systems For decades, the classification system presented by Scadding has been used because of its prognostic value [15] . It has also been used as a scoring tool in studies determining therapy response, but is limited by its wide range in inter-rater agreement (kw 0.43 -0.80) [26, 27] . Other scoring systems used in studies investigating therapy response are the International Labor Organization (ILO) classification for radiographs for pneumoconiosis and the Muers scoring system (modified ILO). These perform slightly better than the Scadding staging (kw 0.33 -0.87) and, in addition have demonstrated a correlation between the extent and profusion of components scored and functional parameters [28] . Our study has shown that the reliability of CT scoring is more or less comparable to that of the radiographic scoring. Considering the fact that CT has a higher sensitivity for detecting abnormalities it may, therefore, be more suited for scoring sarcoidosis-related abnormalities and developing a scoring system for future investigations.
Study limitations
One of the limitations of this study is that some CT findings are relatively uncommon in our cohort, which makes it difficult to reliably estimate inter-rater agreement. Honeycombing for instance is an abnormality present in only 4 % of the cases. Although the agreement of scoring this item in our study is high (ICC 0.91), a recent publication on this important feature of fibrotic lung disease reports a considerable variation [29] . An explanation for this could be that in pulmonary sarcoidosis honeycombing is easier to detect compared to fibrotic lung disease in which Usual Interstitial Pneumonia (UIP) is suspected. Second, scoring in this study was performed in a semi quantitative way. This generally results in higher agreement compared to a real continuous or nearest to 5 % scoring system, but comes at the expense of discriminatory power [30] . The question is, however, whether a nearest to 5 % method is desirable, because this could hamper the applicability in daily clinical practice. Last, the effect of training of raters was not adequately investigated due to the lack of pre-and post-training comparison. Although analysis of the data shows that agreement improves when the results of two experienced but untrained radiologists are left out, no firm conclusions can be made on the effect of training on agreement of scoring CT items.
In conclusion, scoring of thoracic sarcoidosis-related abnormal CT findings in a visual semi quantitative manner resulted in fair to excellent inter-rater reliability. Although there is some variation, most of the abnormalities have an ICC greater than 0.60 and can, therefore, be used in future investigations using this scoring system.
